Kamil F Faridi,Devesh Malik,Mohammed Essa et al.
Kamil F Faridi et al.
Background: The American Heart Association PREVENT (Predicting Risk of Cardiovascular Disease Events) equations were recently developed to estimate risk of total cardiovascular disease (CVD), which includes both atherosclerotic CVD (ASCVD) and heart failure (HF).
Differences in US Adult Dietary Patterns by Cardiometabolic Health and Socioeconomic Vulnerability [0.03%]
按心血管代谢健康和社会经济脆弱性分类的美国成年人饮食模式差异
Eric J Brandt,Cindy W Leung,Tammy Chang et al.
Eric J Brandt et al.
Background: Naturally occurring dietary patterns are not well described among individuals with cardiovascular disease (CVD) or cardiometabolic risk factors (i.e., diabetes, hypertension, obesity, and dyslipidemia), particularly considering socioeconomic vulnerability.
Sleep duration and cardiovascular disease causal association: A two-sample Mendelian randomization study [0.03%]
睡眠时长和心血管疾病因果关系的孟德尔随机化研究
Haixia Xu,Peng Xu,Mengqi Li et al.
Haixia Xu et al.
Background: An increasing number of studies have recently suggested a relationship between sleep duration and cardiovascular disease (CVD). However, a correlation between the two has not been studied.
Drug-loaded composite materials based on polysaccharide carriers for alleviating myocardial cell damage [0.03%]
基于多糖载体的载药复合材料在心肌细胞损伤缓解中的应用研究
Lingling Sun,Lifeng Zhu,Xiaoci Li et al.
Lingling Sun et al.
Heart failure, a leading cause of mortality among cardiovascular disease patients, is primarily a consequence of chronic heart failure (CHF) and myocardial tissue damage associated with apoptosis.
Associations between physical activity and CVD-related metabolomic and proteomic biomarkers [0.03%]
身体活动与心血管疾病相关代谢组和蛋白质组生物标志物之间的关系
Örjan Ekblom,Harry Björkbacka,Mats Börjesson et al.
Örjan Ekblom et al.
However, detailed knowledge of associations between PA and cardiovascular disease (CVD) risk markers is limited.
Approaches to predict future type 2 diabetes mellitus and chronic kidney disease: A scoping review [0.03%]
预测2型糖尿病和慢性肾脏病的发病风险的研究方法学现状：系统综述
Anna Bußmann,Christian Speckemeier,Alexandra Ehm et al.
Anna Bußmann et al.
As cardio-renal-metabolic diseases share predicting factors and given the social and economic importance of these diseases, approaches that address multiple relevant diseases such as type 2 diabetes mellitus, chronic kidney disease and cardiovascular disease can be of great interest, especially in time
Sex Differences in Atherosclerotic Cardiovascular Disease Risk in Obstructive Sleep Apnea [0.03%]
阻塞性睡眠呼吸暂停患者的动脉粥样硬化性心血管疾病风险性别差异
Joshua M Bock,Vinyas Shraffi Venkatesh,Virend K Somers
Joshua M Bock
Purpose of review: This review outlines obstructive sleep apnea (OSA) associated atherosclerotic cardiovascular disease (ASCVD) risk and highlights emerging data suggestive of sex differences.
Efficacy and safety of combination therapy Ezetimibe 10/rosuvastatin 40 in Egyptian patients at very high risk of atherosclerotic cardiovascular disease [0.03%]
依折麦布联合罗苏伐他汀在埃及动脉粥样硬化性心血管病极高危患者中的疗效和安全性研究
Mohamed Sobhy,Hala Mahfouz Badran,Mahmoud Hassanein et al.
Mohamed Sobhy et al.
Background: Lipid-lowering therapies (LLT) are well-established in reducing cardiovascular complications and improving outcomes in patients with atherosclerotic cardiovascular disease (ASCVD).
Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics [0.03%]
动脉粥样硬化斑块的细胞组成：单细胞组学驱动的研究进展
Esra Cetin,Anne-Catherine Raby
Esra Cetin
Atherosclerosis, a chronic inflammatory condition of the arterial cell wall, is the leading cause of cardiovascular disease (CVD) and death.
耗时 0.38856 秒，为您在
48206918
条记录里面共找到 10000 篇文章 [XML]